Copyright
©The Author(s) 2022.
World J Diabetes. Oct 15, 2022; 13(10): 877-887
Published online Oct 15, 2022. doi: 10.4239/wjd.v13.i10.877
Published online Oct 15, 2022. doi: 10.4239/wjd.v13.i10.877
Figure 3 Assessment of the safety of human umbilical cord blood-mesenchymal stem cell treatment.
A-C: Leukocytes, hepatic and renal function; D-F: Antigen associated with tumor. aP < 0.05.
- Citation: Lian XF, Lu DH, Liu HL, Liu YJ, Han XQ, Yang Y, Lin Y, Zeng QX, Huang ZJ, Xie F, Huang CH, Wu HM, Long AM, Deng LP, Zhang F. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus. World J Diabetes 2022; 13(10): 877-887
- URL: https://www.wjgnet.com/1948-9358/full/v13/i10/877.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i10.877